ClearanceBrief
Recall Z-1008-2023 ยท QJR Reagents, 2019-Novel Coronavirus Nucleic Acid

Meridian Bioscience Inc

Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700

DateJan 20, 2023 (initiated Dec 15, 2022)
StatusOpen, Classified
ReasonLeakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2
Root causeProcess control
ActionMeridian Bioscience issued Urgent Medical Device Recall on 12/15/22 via email. The letter states reason for recall, health risk and action to take: REQUIRED ACTIONS: " Inspect the rotor, ring, and chamber walls of the Revogene instrument for signs of leakage (e.g., dried spots). Contact Meridian Bioscience Technical Service if any signs of leakage were detected. " If leakage is suspected, clean the Revogene, MOCK PIEs, and surrounding workspace using the instructions in the Revogene operator's manual. " Review current inventory and segregate any remaining stock. " Discontinue use of any remain
Quantity92 kits
DistributionUS Nationwide distribution in the states of AZ, CA, IN, KS, KY, LA, MI, MN, NC, NY, OR, TX.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

This recall record lists no 510(k) number.